SARS-CoV-2主要蛋白酶的zymogene形式:药物发现的离散目标

Pavel Novotný1, Jana Humpolíčková2, Veronika Nováková3

  • 1Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic; Faculty of Science, Department of Physical and Macromolecular Chemistry, Charles University in Prague, Prague, Czech Republic.

PubMed
概括

研究人员开发了研究SARS-CoV-2主要蛋白酶 (Mpro) 处理的工具. 他们找到了分离前体Mpro的方法,并确定了针对成熟和前体形式的抑制剂,有助于理解病毒生命周期.